The most aggressive and invasive tumor cells often reside in hypoxic microenvironments and rely heavily on rapid anaerobic glycolysis for energy production. This switch from oxidative phosphorylation to glycolysis, along with up-regulation of the glucose transport system, significantly increases the release of lactic acid from cells into the tumor microenvironment.
Introduction
The tumor microenvironment provides metabolic challenges to tumor cells (1) .
Intermittent hypoxia, induced by alterations in blood flow, changes expression of genes involved in glucose metabolism through the transcription factor, hypoxia inducible factor 1 (HIF1) (2) (3) (4) . Cells switch from dependence on oxidative phosphorylation to accelerated glycolysis for their energy production (4) . This glycolytic switch increases the production of lactic acid reducing extracellular pH (pH e ) (5) . Ultimately, this condition becomes imprinted so that it is maintained even in the presence of oxygen, which was described by Otto Warburg nearly 100 years ago and coined the "Warburg Effect" (6) (7) (8) . Cancer cells that adapt to these conditions proliferate rapidly and are resistant to both radiation and chemotherapy (4) . Normal cells in this environment become apoptotic and suffer cell death. This leads to increased space in which cancer cells expand. Thus, the glycolytic phenotype is advantageous for cancer progression and metastasis (3, 4, 8, 9) .
To accommodate the increasing concentration of lactic acid inside cells, it has been proposed that proton-specific transporters are induced in cancer cells to normalize intracellular pH (pH i ) (5) . Indeed, it has been shown that pH i in the cytoplasm of tumor cells (pH 7.2-7.4) is similar to that of normal cells (10, 11) . However, the pH e surrounding tumor cells is strongly acidic (pH 6.5-6.8) (11) . One of the key players in maintaining the relationship between pH i and pH e in tumor cells is thought to be the monocarboxylate transporters (MCT1 and MCT4) (12, 13) .
These transporters co-transport lactate with a proton. Other proteins that may participate in pH regulation include the Na + /H + exchanger (NHE1), the Na + /HCO 3 -co-transporter (NBCn1) and the vacuolar ATPase (vATPase) (12, (14) (15) (16) (17) (18) . Previously published studies performed using glycolytic-deficient cells showed that CO 2 might also contribute to acidification of the tumor microenvironment (19, 20) . CO 2 is itself a weak acid oxide and can react with water to form HCO 3 -and a H + . This process occurs naturally but is enhanced by as much as 1000-fold by carbonic anhydrase family (CAs). CAs are a group of metalloenzymes that consists of five distinct classes, including the α-CAs which is the only class found in humans (21, 22) . As shown below, the CA isoforms catalyze a reversible reaction (Overall) and have the potential to produce CO 2 , HCO 3 − , and protons to create the pH differential across the plasma membrane of cancer cells. In the first of two independent stages, CO 2 undergoes hydration within the active site to form a Zn-bound bicarbonate, which is subsequently exchanged for H 2 O releasing the bicarbonate (Equation 1). In the second stage, the Zn-bound water is deprotonated regenerating the Zn-bound hydroxyl (Equation 2). This second step is regulated by the proton shuttle histidine (His) residue, which can adopt either an "in' and an "out" conformation. The α-class of CAs is made up of twelve catalytically active isoforms that differ in tissue distribution and subcellular localization (23) . Of the human isoforms, only membrane bound carbonic anhydrase IX (CA IX) and carbonic anhydrase XII (CA XII) have been linked to cancer (10, 23) Both isoforms display their catalytic domains from the exofacial side of the plasma membrane (22) . More attention has been placed on CA IX, as this isoform is upregulated by hypoxia, is associated with more aggressive forms of cancer, and is predictive of poor patient outcome (24) (25) (26) (27) . It also is considered a therapeutic target for many hypoxic tumors (28) . There is additional evidence that CA IX forms functional interactions with specific ion transporters accelerating their activity (24, 29, 30) . It has been hypothesized that CA IX forms a metabolon with these transporters and CA II to maintain the glycolytic phenotype by 'cycling' substrates between tumors cells and the microenvironment to regulated pH i (10, 16, 23, 24, (29) (30) (31) . Our lab, and others, have also hypothesized that CA IX serves to regulate pH e by responding to changes in substrate concentration (10, 19, 20) . As pH e decreases, CA IX sequesters protons in the form of CO 2 and H 2 O through the dehydration reaction (27, 32, 33) . As pH e increases CA IX produces HCO 3 -and H + via the hydration reaction (27, 33) . Overall, this adjusts the pH to ~6.8.
Exciting new data in the tumor setting supports this hypothesis, leading to the idea that CA IX serves as a pH-stat within the tumor microenvironment providing a survival and metastatic
advantage to cancer cells that adopt the glycolytic phenotype (34) . This role also prevents overacidification, which would ultimately lead to the death of both normal and cancer cells (34) .
Previous work has shown that the MCT transporters interact with CA IX (24, 30) .
Recently it has been shown that expression of CA IX increases MCT transport activity by a noncatalytic mechanism involving the H + shuttle mechanism mediated by His200 in CA IX (24, 30) , which is analogous to His64 in the ubiquitous, cytosolic CA II isoform (35, 36 
Experimental Section

Cell culture and hypoxia
The MCF10A cells were plated at a density of 20,000 cells/mL in 10 cm dishes, and cultivated in in DMEM/Ham's F12 medium, supplemented with 5% horse serum (Sigma Aldrich), 10 µg/mL insulin, 20 ng/mL epidermal growth factor (EGF) (Upstate Biochem) and 100 ng/mL dexamethasone (Sigma). T47D cells were plated in 10 cm dishes at 20,000 cells/mL and maintained in McCoys 5A medium supplemented with 10% FBS and 10 µg/mL insulin. MCF7 cells, plated in 10 cm dishes at 20,000 cells/mL, were maintained in DMEM supplemented with 10% FBS and 0.01 µM estrogen (Sigma Aldrich). UFH-001 and MDA-MB-231-LM2 cells were plated in 10 cm dishes at a density of 10,000 cells/mL and maintained in DMEM supplemented with 10% FBS. All cell lines were maintained at 37 °C in humidified air with 5% CO 2 .
Experiments were conducted when cells achieved ~70% confluency, unless otherwise specified. (Santa Cruz, sc-50329), CAIX (M75 monoclonal, gift from Dr. Egbert Oosterwijk), CAII (Novus, NB600-919), CAXII (R&D, AF2190), and GAPDH (Cell Signaling, 5174). The GLUT1 antibody was made in the lab of SC Frost and has been previously characterized for specificity (42) .
Knockdown and deletion of CA expression
LentiCRISPR v2 was used to knockout CA IX expression in UFH-001 cells as previously described (27) . GFP expression was monitored to confirm efficiency of transduction. Stably transduced UFH-001 and T47D cells were established by puromycin (2 µg/mL) selection (Sigma Aldrich). CA IX knockout and CA XII knockdown were confirmed by western blotting.
Glucose transport assay
Glucose transport activity was measured according to previously published methods (43) . For these experiments, we plated MCF10A and T47D cells, along with CA IX KO (UFH-001) cells and CA XII KO (T47D) cells at a density of 30,000 cells/35 mm plate. UFH-001 cells were plated at 10,000 cells/plate. At 50-75% confluency, the cells were divided into two groups.
The control group was incubated under normal culture conditions, while the second group was exposed to 16 h of hypoxia. Cells were equilibrated in KRP buffer for 10 min at 37 o C. Cells were then exposed or not to 40 µM cytochalasin B (a glucose transporter specific inhibitor that provides non-specific uptake), from a stock dissolved in DMSO for 10 min. This was followed by previously reported (45) . 100 mM stock concentrations of these inhibitors were prepared in DMSO and diluted to specific concentrations as specified in the Results section. The final DMSO concentration was ≤ 0.5%.
Lactate determination
MCF10A and T47D cells, along with CA IX KO (UFH-001) cells and CA XII KO (T47D)
cells were plated at a density of 30,000 cells/35 mm plate, while UFH-001 cells were plated at 10,000 cells/plate. All cells were grown to 50-70% confluence. Cells were fed with appropriate medium and then exposed to 16 h of hypoxia at different pH values. Medium was collected from each plate at the end of the exposure time and immediately assayed for lactate. Alternatively, cells were handled similarly as for the glycolytic assay, i.e., fresh medium, adjusted to either pH 7.4 or 6.8, was provided followed by a 3 h incubation at 37°C in a CO 2 incubator at which point medium samples were collected for lactate analysis (46) . For those cells initially exposed to hypoxia, DFO was added as a chemical substitute. Lactate was determined using a coupled enzyme reaction. Data are reported as nmol normalized to protein concentration.
Structural representation of the interaction between USB compounds and CAs
X-ray crystallography structures of USB compounds in complex with CA II and a CA IX mimic (analogous site generated mutagenesis of residues in the active site of CA II to resemble wildtype CA IX) were previously obtained and the data deposited in the protein data bank (35) .
In silico modelling experiments of the same USBs modeled into the active site of CA XII were also previously performed and published (45) . These structures were used to illustrate USB binding in the active sites of CA II, IX and XII relative to His64 (CA II numbering). Figures were made using PyMol.
Statistics
RNA seq data for normoxic vs hypoxic cells, along with the CA activity assay, were analyzed using the Student's t test. All p values were based on two-tailed analysis and p < 0.05 was considered statistically significant. Statistical analysis was performed using the Prism 7
software. Glucose transport activity, glycolytic activity (GlycoPER), extracellular lactate, and pH e data were analyzed with R (version 3.4.1) using RStudio (V.1.0.153). ANOVA models were generated with the lm function using type III Sum of Squares, and Tukey posthoc comparisons among groups were conducted with the LSD test function of Agricolae.
Results
The MCT proton transporter family is coordinately expressed with CA IX in breast cancer cells and tissue
To compare the expression profiles of ion transporters with molecular subtypes of breast cancer, we compared protein expression of a specific set of transporters, including V-ATPase, To evaluate the potential for proton transporter function, in vivo, we generated xenografts of UFH-001 (duplicate tumors #1 and #2, Figure 1C ) and TNBC patient derived tumor grafts (PDX) (duplicate tumors, #3 and #4, Figure 1C ). In UFH-001 xenografts, both isoforms of MCT were expressed, although MCT4 expression patterns were higher relative to MCT 1. NHE1 expression was variable but appeared more highly expressed than in the cultured cells. There An RNA sequencing experiment using the UFH-001 cells under normoxic and hypoxic conditions support the protein expression pattern. A total of 1,487 genes were upregulated under hypoxic conditions and 1,459 were down regulated (p-value ≤ 0.05). A heat map was generated from 623 DEG (differentially expressed genes) that had log2 scores > 1 and FDR (false discovery rate, or q-value) ≤ 0.05 (Figure 2A ). This showed a distinct transcriptional profile between normoxic and hypoxic conditions. From these data bases, we selected information specific to the ion transporters and CA family members ( Figure 2B ). Very few transcripts of NHE1 and V-ATPase were detected and expression of neither was sensitive to hypoxia ( Figure 2B ). MCT1 and MCT4 showed higher level of transcripts than those for NHE1
and vATPase. MCT1 transcription was significantly upregulated by hypoxia (q-value = 0.0013) but this did not translate into higher levels of MCT1 protein ( Figure 1A ). Also, of note is the prognosticator when queried across all breast cancer subtypes as a group. Overexpression of NHE1 also predicts better outcomes (Supplemental Figure 2B) . In contrast, MCT1
overexpression is associated with decreased survival (Supplemental Figure 2C ) and MCT4 is an even stronger predictor than MCT1 of poor patient survival (Supplemental Figure 2D ). This suggests that the MCT transporter family is associated with more aggressive types of cancer and is associated with CA IX expression (Figure 1 ), another marker for poor patient outcome.
CA IX expression, but not that of CA XII, regulates proton efflux in UFH-001 cells
The glycolytic rate assay (developed by Seahorse Biosciences) was used to determine proton excretion rates from glycolysis (GlycoPER) in UFH-001 and T47D cells relative to the control MCF10A cells (Figure 3 ). This assay simultaneously measures extracellular acidification rates (ECAR) and oxygen consumption rates (OCR). In this version of the assay, cells are provided glucose (10 mM) at the start of the experiment (thus the high initial rates of ECAR in Figure 3A ) and then treated with a cocktail containing rotenone/antimycin (Rot/AA) to block oxidative phosphorylation followed by deoxyglucose (DG) to block glycolysis. Raw data are shown in Figures 3A and 3B for these two parameters. Figures 3C and 3D represent the calculated rates of proton extrusion that subtract out the contribution of CO 2 derived from mitochondrial activity to extracellular acidification. The resulting value, GlycoPER, is the rate of protons extruded into the extracellular medium presumably from glycolysis in real time. To maintain the hypoxic phenotype in the absence of a hypoxic environment, the hypoxic state during the assay was mimicked by the addition of 100 µM desferroxamine mesylate (DFO) to maintain the stability of HIF1α. CA and ion transporter expression, in the presence of DFO, were comparable to those observed under hypoxic conditions (Supplemental Figure 2) . We also exposed cells, during the assay, to buffer that was initially at pH 7.4 or pH 6.8, the latter of which is observed in hypoxic tumors. We have shown previously that these different pH conditions alter the activity of CA IX and CA XII, which might change the rate of extracellular proton production based on changes in CA activity (which we confirmed here: see Figure 5 ).
GlycoPER data for UFH-001 cells and T47D cells are shown in Figures 3C and 3D respectively. In each plot, data are compared to the MCF10A cells, under all tested conditions.
Under normoxic conditions at pH 7.4, UFH-001 cells produce significantly higher proton efflux rates relative to MCF10A cells ( Figure 3C ). The same is observed under hypoxic conditions. At pH 6.8, the efflux rate in UFH-001 cells is significantly reduced relative to pH 7.4 under both normoxic and hypoxic conditions. CA IX knockout further reduced GlycoPER relative to EV controls under all conditions. We conclude that pH and CA IX expression have independent effects on GlycoPER. The GlycoPER pattern in T47D cells was strikingly different from UFH-001 cells ( Figure 3D ). In fact, there was little statistical significance across the conditions, although an upward trend in proton efflux was observed in CA XII knockdown cells relative to EV control T47D cells. The GlycoPER rate in UFH-001 EV cells was about 2-3 times higher than that in T47D cells. Overall, these data suggest that CA IX expression, but not that of CA XII, contributes to extracellular acidification
CA expression does not influence glucose transporter expression or activity
Cells in culture exhibit increased glycolysis perhaps because they have an unrestricted source of glucose. Cancer cells also exhibit increased glucose uptake and enhanced glycolytic rates as part of the glycolytic switch (4). This is due, in part, by increased constitutive expression of GLUT1, which consequently increases glucose uptake into the cell (50) . We demonstrate in Figure 2C that the level of GLUT1 transcripts in UFH-001 cells was high and that the number of transcripts increased in response to hypoxia (~ 2-fold). GLUT3, although transcript number was lower by nearly 1000-fold relative to GLUT1, was strongly regulated by hypoxia. It seems unlikely that GLUT3 contributes significantly to glucose uptake in these cells, although we did not analyze GLUT3 protein expression. We have confirmed the strong protein expression of GLUT1 in UFH-001 and the control MCF10A but much lower expression in the luminal T47D cells ( Figure 4A ). We also show that GLUT1 expression in both the UFH-001 and Figure 4B demonstrates that basal glucose transport in UFH-001 cells was greater than that observed for either MCF10A or T47D cells. Hypoxia increased uptake but for the most part, these values were not statistically significant. We have observed this trend before (43) which may reflect the high constitutive expression of GLUT1 induced by the transformation process itself. Knockdown of CA IX or CA XII in UFH-001 and T47D cells, respectively, did not significantly alter glucose uptake relative to EV controls. Therefore, the effect exerted by CA IX on proton efflux is independent of glucose.
Low pH increases activity of both CA IX and CA XII
To determine the effect of pH on CA activity, we have calculated the first order rate constants for CA IX activity in UFH-001 cells ( Figure 5A ) and CA XII activity in T47D cells ( Figure 5B than changes in CA IX activity: about 50% in both normoxic and hypoxic cells. In previous studies, we have shown that the increase in activity at low pH is related in part to the acceleration of the dehydration activity of CA IX (favoring proton consumption) relative to its hydration activity (producing protons). That low pH is less influential with respect to CA XII may be related to its reduced stability compared to that of CA IX which is stable to values of pH as low as 3.0 (51).
CA catalytic activity is not required for decreased proton efflux in breast cancer cells
Ureido substituted benzene sulfonamides (USBs) are potent inhibitors of CA IX and CA XII, over the off-target cytosolic and ubiquitously expressed CA II, as measured by stop flow kinetics (SFK) of purified recombinant proteins (35, 44) . Using MIMS, we have shown that these same inhibitors selectivity target and inhibit CA IX activity over CA XII in UFH-001 cells versus T47D cells, respectively (45) . Thus, we have used these inhibitors (the structure of which are shown in Figure 6A ) to determine if the reduction of GlycoPER in CA IX KO cells, relative to the EV control UFH-001 cells, is related to its catalytic activity ( Figure 6B ). This does not appear to be the case, as the inhibitors did not significantly affect the rate of GlycoPER under either normoxic or hypoxic conditions. We conclude that the expression of CA IX, but not its activity, influences proton efflux/acidification.
Glucose transport rates in UFH-001 cells were not affected by the USBs, either (Supplemental Figure 3A) . The same was true for glucose transport activity in T47D cells (Supplemental Figure 3B) . Again, these data suggest that neither CA IX nor CA XII directly affects glucose uptake.
CA expression does not affect extracellular lactate concentrations in breast cancer cells
Glucose metabolism in cancer cells is accelerated and leads to the formation of lactic acid because of the switch from aerobic to anaerobic metabolism. This leads to reduced extracellular pH through export of lactate. Here, we determined if changes in pH or CA expression affect extracellular lactate concentrations ( Figures 7A and 7B ) under conditions that replicate the protocol used for the GlycoPER assays ( Figures 3A and 3B ). We first exposed cells to either normoxic or hypoxic conditions for 16 h. Then, cells were washed and exposed additionally to normoxic conditions or DFO for 3 h at different pH values. In Figure 7A , we show that lactate export in UFH-001 was significantly higher under all conditions relative to the MCF10A controls, similarly to the increase in proton efflux as might be expected ( Figure 3C ).
However, there were some striking differences between the GlycoPER data and the lactate measurements in the UFH-001 cells with respect to pH, and the knockdown experiments. pH had no effect on lactate levels, and knockdown of CA IX trended toward an increase in lactate, although not significantly. Yet, both reduced pH and loss of CA IX independently reduced the apparent proton efflux in the GlycoPER assay ( Figure 3C ). Lactate concentrations in the medium from T47D cells were also significantly higher than that of MCF10A cells under all conditions ( Figure 7B ). However, neither hypoxia, pH, nor CA XII knockdown affected lactate concentrations. These data are similar to the proton efflux as presented in the GlycoPER results for T47D cells ( Figure 2D ). These data suggest that the effect of CA IX on proton efflux is independent of not only glucose uptake but glycolysis, as well.
Discussion
Because proton export is dependent on transporters, our first goal was to determine the expression patterns of these across luminal and triple negative breast cancer cells. Our studies
show that members of the ion transport family are differentially expressed in breast cancer cells The glycolytic rate assay revealed that CA IX expression is associated with high rates of proton export relative to either the control MCF10A cells or the T47D cells at pH 7.4 ( Figure 3 ).
Because MCT1 and MCT4 are the only ion transporters overexpressed in the UFH-001 cells, it is likely that they are responsible for both lactate and proton transport. Catalytically, CA IX at pH 7.4 might be expected to participate in extracellular proton production (19, 20, 27, 34, 45) as this pH favors the hydration reaction leading to the production of protons in the extracellular space (33) . Indeed, it appears that proton production increases in normal UFH-001 cells, at pH 7.4, based on the GlycoPER assay ( Figure 3C ). We would also expect that at pH 6.8, where the dehydration reaction is favored (33) , that proton production would decrease. This is exactly what we observed, in fact, under both normoxic and hypoxic conditions in the GlycoPER assay ( Figure 3C ). (19, 20, 34) .
That said, blocking CA activity with USBs had no effect on proton efflux ( Figure 6 ).
Given this result, it was surprisingly that knockdown of CA IX reduced the rate of proton production in the extracellular space, under all conditions, to values that were not statistically different from the values observed at pH 6.8 ( Figure 3C ). This suggests that without CA IX protein proton flux is limited. This questions the role of CA IX catalytic activity in this setting.
Jamali et al. (24) have demonstrated that CA IX augments MCT1 and MCT4 transport activity, but not expression, the latter of which is corroborated by our present studies. These authors also proposed that the effect of CA IX on MCT function occurs via a non-catalytic mechanism (24) . Specificallly, they showed that the histidine involved in proton shuttling in CA IX (Equation GAPDH was used as a loading control. were then incubated for another 3 h at either pH 7.4 or pH 6.8, after which lactate concentrations was determined. During those 3 h, hypoxic cells were exposed to desferroxamine mesylate DFO (100 µM). Panel B) T47D cells (EV control and CA XII KO cells) and MCF10A cells were exposed to normoxic or hypoxic conditions for 16 h. Cells were then incubated for another 3 h at either pH 7.4 or pH 6.8, after which lactate concentrations was determined. During those 3 h, hypoxic cells were exposed to DFO (100 µM). n = 3 for all data sets. 
